IOVANCE BIOTHERAPEUTICS INC Chart calendar Iovance Biotherapeutics Inc
92032e1d6e2de.LAaOTQvhGmvAotG3GcZrYbAlJUUOTrsnBGXxhBTnF-0.WWXcAELQKC2l6Lntdq8MFu9KVRB3IMx3clWWtCaAe7ludt48YZJKLJLgug~56e495d4af736d2844e7a42ff872137d
Upcoming events on Iovance Biotherapeutics Inc
Past events on Iovance Biotherapeutics Inc
| 2024-05-13 02:00 pm | Citizens JMP Life Sciences Conference |
| 2024-05-09 04:30 pm | Q1 2024 Earnings Call |
| 2024-05-09 04:01 pm | Q1 2024 Earnings Release |
| 2024-04-30 02:30 pm | Chardan Genetic Medicines & Cell Therapy Manufacturing Summit |
| 2024-03-26 01:30 pm | H.C. Wainwright Cell Therapy Virtual Conference |
| 2024-03-12 10:45 am | Barclays Global Healthcare Conference |
| 2024-03-04 11:10 am | TD Cowen Health Care Conference |
| 2024-02-28 04:30 pm | Q4 2023 Earnings Call |
| 2024-02-28 04:01 pm | Q4 2023 Earnings Release |
| 2024-02-16 04:15 pm | AMTAGVI™ FDA Approval Call |
| 2023-11-07 04:30 pm | Q3 2023 Earnings Call |
| 2023-11-07 04:01 pm | Q3 2023 Earnings Release |
| 2023-11-04 12:00 pm | Society for Immunotherapy of Cancer Meeting - Long-term Efficacy and Safety of Lifileucel Tumor |
| 2023-11-04 12:00 pm | Society for Immunotherapy of Cancer Meeting - Study of Lifileucel Tumor Infiltrating Lymphocyte |
| 2023-11-03 12:00 pm | Society for Immunotherapy of Cancer Meeting |
| 2023-10-21 09:15 am | European Society for Medical Oncology Congress |
| 2023-09-11 11:15 pm | International Association for the Study of Lung Cancer World Conference - Adam J. Schoenfeld |
| 2023-09-11 06:00 am | International Association for the Study of Lung Cancer World Conference - Dean Fennell |
| 2023-09-07 12:45 pm | Wells Fargo Healthcare Conference |
| 2023-08-08 04:30 pm | Q2 2023 Earnings Call |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 1,19 2,12 -44.03% | 153 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | -261 -256 -1.87% | -340 -330 -2.8% | -390 -389 -0.09% | -449 -420 -6.87% | -374 |
|
EBIT Million USD | Released Forecast Spread | -207 -196 -5.73% | -262 -260 -0.63% | -343 -331 -3.63% | -399 -395 -0.91% | -461 -451 -2.01% | -372 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -198 -187 -5.92% | -260 -257 -0.88% | -342 -330 -3.78% | -396 -394 -0.52% | -448 -440 -1.63% | -357 |
|
Net income Million USD | Released Forecast Spread | -198 -187 -5.92% | -260 -257 -0.92% | -342 -330 -3.78% | -396 -394 -0.52% | -444 -439 -1.17% | -356 |
|
EPS USD | Released Forecast Spread | -1,59 -1,50 -6.14% | -1,88 -1,85 -1.9% | -2,23 -2,15 -3.63% | -2,49 -2,49 -0.15% | -1,89 -1,88 -0.8% | -1,31 |
| Announcement Date | 25/02/20 | 25/02/21 | 24/02/22 | 28/02/23 | 28/02/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,24 5,38 -95.57% | 0,47 4,89 -90.4% | 0,48 1,40 -65.55% | 0,72 2,09 -65.76% | 30,8 | 61,2 | 78,2 | 89,3 | 103 |
|
EBITDA Million USD | Released Forecast Spread | -89,9 -100 10.26% | -97,5 -101 3.19% | -97,9 -106 7.78% | -104 -105 1.12% | -108 -110 1.56% | -107 | -128 | -122 | -129 | -139 | ||||
|
EBIT Million USD | Released Forecast Spread | -91,7 -100 8.67% | -99,7 -96,0 -3.87% | -100 -102 1.28% | -107 -103 -3.46% | -111 -111 0.11% | -110 -172 36.16% | -118 -109 -8.53% | -121 -112 -8.09% | -118 -111 -5.72% | -93,7 | -72,5 | -66,7 | -72,0 | -65,4 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -91,6 -100 8.5% | -99,3 -95,9 -3.55% | -99,6 -100 0.76% | -105 -103 -2.07% | -107 -131 17.98% | -107 -171 37.27% | -115 -107 -7.19% | -118 -111 -6.41% | -114 -113 -1.19% | -93,0 | -74,9 | -72,1 | -70,9 | -64,4 |
|
Net income Million USD | Released Forecast Spread | -91,6 -100 8.5% | -99,3 -95,9 -3.55% | -99,6 -100 0.49% | -105 -103 -2.07% | -107 -131 17.98% | -107 -171 37.55% | -114 -107 -6.04% | -116 -111 -4.97% | -113 -113 0.02% | -93,0 | -75,0 | -72,2 | -70,9 | -64,4 |
|
EPS USD | Released Forecast Spread | -0,58 -0,64 9.38% | -0,63 -0,61 -4.05% | -0,63 -0,64 1.14% | -0,64 -0,64 -0.43% | -0,50 -0,75 33.42% | -0,47 -0,85 44.79% | -0,46 -0,45 -1.77% | -0,45 -0,44 -2.51% | -0,42 -0,43 2.33% | -0,35 | -0,28 | -0,26 | -0,20 | -0,17 |
| Announcement Date | 05/05/22 | 04/08/22 | 03/11/22 | 28/02/23 | 09/05/23 | 08/08/23 | 07/11/23 | 28/02/24 | 09/05/24 | - | - | - | - | - |
More events
Past sector events for Iovance Biotherapeutics Inc
| 2024-05-09 | SEEGENE, INC.: Q1 2024 Earnings Release |
| 2024-05-09 04:05 pm | GUARDANT HEALTH, INC.: Q1 2024 Earnings Release |
| 2024-05-09 04:01 pm | IOVANCE BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-08 04:05 pm | MARAVAI LIFESCIENCES HOLDINGS, INC.: Q1 2024 Earnings Release |
| 2024-05-08 04:05 pm | EXACT SCIENCES CORPORATION: Q1 2024 Earnings Release |
| 2024-05-07 04:05 pm | VERACYTE, INC.: Q1 2024 Earnings Release |
| 2024-04-26 | BGI GENOMICS CO., LTD.: Q1 2024 Earnings Release |
| 2024-04-12 | BGI GENOMICS CO., LTD.: Q4 2023 Earnings Release |
| 2024-02-28 04:05 pm | CAREDX, INC: Q4 2023 Earnings Release |
| 2024-02-28 04:01 pm | IOVANCE BIOTHERAPEUTICS, INC.: Q4 2023 Earnings Release |